NO20085213L - Nye pyridinanaloger - Google Patents

Nye pyridinanaloger

Info

Publication number
NO20085213L
NO20085213L NO20085213A NO20085213A NO20085213L NO 20085213 L NO20085213 L NO 20085213L NO 20085213 A NO20085213 A NO 20085213A NO 20085213 A NO20085213 A NO 20085213A NO 20085213 L NO20085213 L NO 20085213L
Authority
NO
Norway
Prior art keywords
new pyridine
pyridine analogs
formula
analogs
new
Prior art date
Application number
NO20085213A
Other languages
English (en)
Inventor
Johan Johansson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20085213L publication Critical patent/NO20085213L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Foreliggende oppfinnelse angår visse nye pyridinanaloger med formel ( I ) Formel ( I ) til prosesser for fremstilling av slike forbindelser, til deres nytte som P2Y12 inhibitorer og som anti-trombotiske midler etc, anvendelse av dem som medikamenter i kardiovaskulære sykdommer så vel som farmasøytiske preparater inneholdende dem.
NO20085213A 2006-07-04 2008-12-15 Nye pyridinanaloger NO20085213L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0601465 2006-07-04
PCT/SE2007/000641 WO2008004941A1 (en) 2006-07-04 2007-07-02 New pyridine analogues

Publications (1)

Publication Number Publication Date
NO20085213L true NO20085213L (no) 2009-01-13

Family

ID=38894820

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20085213A NO20085213L (no) 2006-07-04 2008-12-15 Nye pyridinanaloger

Country Status (13)

Country Link
US (2) US20090312368A1 (no)
EP (1) EP2041112A1 (no)
JP (1) JP2009542641A (no)
KR (1) KR20090031605A (no)
CN (1) CN101506193A (no)
AU (1) AU2007270081A1 (no)
BR (1) BRPI0713401A2 (no)
CA (1) CA2655628A1 (no)
IL (1) IL195979A0 (no)
MX (1) MX2008016551A (no)
NO (1) NO20085213L (no)
WO (1) WO2008004941A1 (no)
ZA (1) ZA200810647B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070107024A (ko) * 2005-01-06 2007-11-06 아스트라제네카 아베 신규 피리딘 화합물
AU2006267148A1 (en) * 2005-07-13 2007-01-18 Astrazeneca Ab New pyridine analogues
TW200811133A (en) * 2006-07-04 2008-03-01 Astrazeneca Ab New pyridine analogues III 334
EP2044024A4 (en) * 2006-07-04 2011-06-29 Astrazeneca Ab NEW ANALOGUES OF PYRIDINE
WO2008004941A1 (en) * 2006-07-04 2008-01-10 Astrazeneca Ab New pyridine analogues
US20110059981A9 (en) * 2006-07-04 2011-03-10 Astrazeneca Ab New Pyridine Analogues V
US20080171732A1 (en) * 2007-01-12 2008-07-17 Astrazeneca Ab New Pyridine Analogues IX 519
US20080176827A1 (en) * 2007-01-12 2008-07-24 Astrazeneca Ab New Pyridine Analogues VII 543
US20090018166A1 (en) * 2007-07-13 2009-01-15 Astrazeneca Ab New Pyridine Analogues X 161
WO2010005385A1 (en) * 2008-07-07 2010-01-14 Astrazeneca Ab 2-amino-6-alkyl substituted pyridine derivatives useful as p2y12 inhibitors 308
US9539246B2 (en) 2011-08-30 2017-01-10 University Of Utah Research Foundation Methods and compositions for treating nephrogenic diabetes insipidus

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156758A (en) * 1999-09-08 2000-12-05 Isis Pharmaceuticals, Inc. Antibacterial quinazoline compounds
EP1257550B1 (en) * 2000-02-04 2005-11-16 Portola Pharmaceuticals, Inc. Platelet adp receptor inhibitors
US6906063B2 (en) * 2000-02-04 2005-06-14 Portola Pharmaceuticals, Inc. Platelet ADP receptor inhibitors
US7452870B2 (en) * 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7132408B2 (en) * 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7018985B1 (en) * 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
FR2820057A1 (fr) * 2001-01-30 2002-08-02 Ct De Transfert De Technologie Membrane pour chambre d'encapsulation de cellules produisant au moins une substance biologiquement active et organe bio-artificiel comprenant une telle membrane
US7790736B2 (en) * 2003-08-13 2010-09-07 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
CA2539882A1 (en) * 2003-10-03 2005-04-21 Portola Pharmaceuticals, Inc. Substituted isoquinolinones
US7335648B2 (en) * 2003-10-21 2008-02-26 Inspire Pharmaceuticals, Inc. Non-nucleotide composition and method for inhibiting platelet aggregation
US7749981B2 (en) * 2003-10-21 2010-07-06 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
US7504497B2 (en) * 2003-10-21 2009-03-17 Inspire Pharmaceuticals, Inc. Orally bioavailable compounds and methods for inhibiting platelet aggregation
NZ551603A (en) * 2004-06-24 2010-11-26 Incyte Corp N-substituted piperidines and their use as pharmaceuticals
KR20070107024A (ko) * 2005-01-06 2007-11-06 아스트라제네카 아베 신규 피리딘 화합물
AU2006267148A1 (en) * 2005-07-13 2007-01-18 Astrazeneca Ab New pyridine analogues
WO2008004941A1 (en) * 2006-07-04 2008-01-10 Astrazeneca Ab New pyridine analogues
EP2044024A4 (en) * 2006-07-04 2011-06-29 Astrazeneca Ab NEW ANALOGUES OF PYRIDINE
US20110059981A9 (en) * 2006-07-04 2011-03-10 Astrazeneca Ab New Pyridine Analogues V
TW200811133A (en) * 2006-07-04 2008-03-01 Astrazeneca Ab New pyridine analogues III 334
US20080200448A1 (en) * 2007-01-12 2008-08-21 Astrazeneca Ab New Pyridine Analogues VIII 518
US20080176827A1 (en) * 2007-01-12 2008-07-24 Astrazeneca Ab New Pyridine Analogues VII 543
US20080171732A1 (en) * 2007-01-12 2008-07-17 Astrazeneca Ab New Pyridine Analogues IX 519
US20090018166A1 (en) * 2007-07-13 2009-01-15 Astrazeneca Ab New Pyridine Analogues X 161

Also Published As

Publication number Publication date
US20090312368A1 (en) 2009-12-17
CN101506193A (zh) 2009-08-12
BRPI0713401A2 (pt) 2012-04-17
MX2008016551A (es) 2009-02-06
JP2009542641A (ja) 2009-12-03
EP2041112A1 (en) 2009-04-01
KR20090031605A (ko) 2009-03-26
CA2655628A1 (en) 2008-01-10
IL195979A0 (en) 2009-09-01
WO2008004941A1 (en) 2008-01-10
ZA200810647B (en) 2009-12-30
AU2007270081A1 (en) 2008-01-10
US20080009523A1 (en) 2008-01-10

Similar Documents

Publication Publication Date Title
NO20085218L (no) Nye pyridinanaloger
NO20085213L (no) Nye pyridinanaloger
NO20073101L (no) Nye pyridinforbindelser
NO20085214L (no) Nye pyridinanaloger
NO20076682L (no) Nye pyridinanaloger
NO20085212L (no) Nye pyridinanaloger
NO20071504L (no) Pyrimidinderivanter.
NO20082124L (no) Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
NO20071246L (no) Kinazolinonderivater og deres anvendelse som B-RAF-inhibitorer.
NO20090835L (no) Nye HIV-reverstranskriptaseinhibitorer
NO20081729L (no) Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer
NO20084202L (no) 4-anilinoquinolin-3-carboksamider som CSF-1R kinase inhibitorer
NO20070339L (no) 1-aza-bicyklo[3 3.1]nonaner
NO20071245L (no) Kinazolinonderivater og deres anvendelse som b-RAF-inhibitorer.
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
PH12014501134B1 (en) 2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication
NO20090628L (no) Pyridizinon derivativater
NO20082709L (no) Kjemiske forbindelser
EP1982982A4 (en) NEW COUMARINE DERIVATIVE WITH ANTITUM EFFECT
TNSN07075A1 (en) Pyrimidine derivatives
TW200732323A (en) Organic compounds
NO20073791L (no) Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer
NO20071074L (no) Substituerte cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer
NO20091683L (no) Kjemiske forbindelser
NO20084352L (no) Dimerer av artemisininderivater, fremstilling derav og terapeutisk anvendelse derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application